CNR Institutional Research Information System

CUSIMANO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 135
NA - Nord America 37
EU - Europa 16
Totale 188
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 120
US - Stati Uniti d'America 37
IT - Italia 16
CN - Cina 10
KR - Corea 5
Totale 188
Salva come PNG Salva come JPEG
Città #
Singapore 89
Santa Clara 11
Boardman 7
Seoul 5
Guangzhou 2
Palermo 2
Forest City 1
Pescara 1
Springfield 1
Totale 119
Salva come PNG Salva come JPEG
Nome #
The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH 11
Isolation of extracellular vesicles from microalgae: Towards the production of sustainable and natural nanocarriers of bioactive compounds 8
Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview 7
The Role of Metaphor in Serious Games Design: the BubbleMumble Case Study 7
Nanoalgosomes: Introducing extracellular vesicles produced by microalgae 6
BubbleMumble Lab: un Mobile Serious Game per l'apprendimento dei concetti legati ai processi di estrazione e funzionalizzazione delle vescicole extracellulari 6
VES4US: Extracellular vesicles from a natural source for tailor-made nanomaterials 5
Antioxidant Bioprospecting in Microalgae: Characterisation of the Potential of Two Marine Heterokonts from Irish Waters 5
The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach 4
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma 4
Emerging Use of Nanotechnology for the Treatment of Liver Diseases 4
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma 4
Post-translational lipidation in extracellular vesicles: chemical mechanisms, biological functions and applications 4
The response to simulated hypogravity is dependent on the proliferation state and temperature in FRTL-5 thyroid cells 4
A general path for large-scale solubilization of cellular proteins: From membrane receptors to multiprotein complexes. 4
BubbleMumble Kart: un Web Serious Game per l'apprendimento dei concetti di base legati alle vescicole extracellulari 4
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 4
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells 3
New landscapes and horizons in hepatocellular carcinoma therapy. 3
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation 3
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 3
Antitumor effects of the novel NF-kappa B inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: Analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production 3
From targets to targeted therapies in Hepatocellular carcinoma 3
Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. 3
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 3
Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine? 3
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells 3
Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. 3
Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway 2
COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. 2
In vitro and in vivo antitumor activity of the proteasome inhibitor MLN2238 in hepatocellular carcinoma cells 2
Changes in desmosomal proteins during liver regeneration after mouse partial hepatectomy 2
Hepatocellular Carcinoma: A Difficult Cancer to Treat 2
GSK-3 in liver diseases: Friend or foe? 2
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 2
Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies 2
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 2
Episodic Ataxia Type 1 mutation F184C alters Zn2+-induced modulation of the human potassium channel Kv1.4-Kv1.1/Kv{beta}1.1. 2
Gene expression profiling of human liver cancer cells following celecoxib treatment. 2
G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 2
Sialylation of host proteins as targetable risk factor for COVID-19 susceptibility and spreading: A hypothesis 2
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 2
Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors 2
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment 2
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 2
Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. 2
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response 2
COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells. 1
Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins) 1
Wnt5a inhibits beta-catenin signaling and proliferation in hepatocyte cultures: Implications in liver regeneration 1
Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. 1
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. 1
Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. 1
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. 1
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells 1
Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. 1
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. 1
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. 1
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells 1
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 1
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells 1
Induction of Apoptosis and Inhibition of Cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 1
Inhibition of cell growth in human hepatocellular carcinoma cells by selective COX-2 inhibitors 1
Non-canonical Wnt signaling during liver regeneration 1
Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. 1
Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels 1
Antitumor activity of the novel small molecule Akt inhibitor SC66 in hepatocellular carcinoma cells. 1
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. 1
Molecular mechanisms of sorafenib action in liver cancer cells. 1
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells 1
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 1
The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism 1
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 1
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. 1
An Episodic Ataxia Type-1 (EA1) mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+ 1
WNT5A Inhibits Hepatocyte Proliferation and Concludes ?-Catenin Signaling in Liver Regeneration 1
Cyclooxygenases in cancer 1
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 1
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. 1
Totale 194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.410
article - articoli 782
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 81
Totale 2.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202424 0 0 0 0 0 0 0 0 1 0 14 9
2024/2025170 29 8 90 40 3 0 0 0 0 0 0 0
Totale 194